willow health semaglutide GLP-1 Weight Loss Medication - Effortless Weight Loss Semaglutide Tablets

please visit my previous articles for a refresher

The injectable drug, initially only used as diabetes medication, is the first drug since Saxenda (2014) approved to treat chronic weight management in the 70% of American adults who are obese or overweight.

Biomarkers and genetic predispositions can help personalize GLP-1 therapy

Learn how this weight loss medication's gastrointestinal side effects may indirectly affect hemorrhoid risk and discover evidence-based prevention strategies to protect your anorectal health while taking tirzepatide.

Diabetes Education Services keeps you up to date with the latest news on FDA approvals and recalls, new medication developments, and distribution improvement.